Quarterly report [Sections 13 or 15(d)]

Condensed Consolidated Statements of Stockholders' Equity (Unaudited)

v3.26.3
Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Preferred Stock [Member]
Series C Convertible Preferred Stock [Member]
Preferred Stock [Member]
Series D Convertible Preferred Stock [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Total
Balance at Dec. 31, 2024 $ 207,414 $ (199,824) $ 7,590
Balance, shares at Dec. 31, 2024 339,132 [1]      
Share-based compensation 315 315
Net loss (1,656) (1,656)
Issuance of preferred stock and warrants in public offering, net of stock issuance costs 21 21
Issuance of preferred stock and warrants in public offering, net of stock issuance costs, shares 1,650        
Balance at Mar. 31, 2025 207,750 (201,480) 6,270
Balance, shares at Mar. 31, 2025 1,650 339,132 [1]      
Balance at Dec. 31, 2024 207,414 (199,824) 7,590
Balance, shares at Dec. 31, 2024 339,132 [1]      
Net loss           (8,433)
Balance at Sep. 30, 2025 215,335 (208,875) 6,460
Balance, shares at Sep. 30, 2025 3,155 393,405 [1]      
Balance at Mar. 31, 2025 207,750 (201,480) 6,270
Balance, shares at Mar. 31, 2025 1,650 339,132 [1]      
Share-based compensation 238 238
Net loss (5,245) (5,245)
Issuance of preferred stock and warrants in public offering, net of stock issuance costs 309 309
Issuance of preferred stock and warrants in public offering, net of stock issuance costs, shares 1,650        
Reclassification of warrants from liability to equity 6,103 6,103
Balance at Jun. 30, 2025 214,400 (206,725) 7,675
Balance, shares at Jun. 30, 2025 3,300 339,132 [1]      
Share-based compensation 253 253
Net loss (1,532) (1,532)
Issuance of Common Stock upon conversion of preferred stock
Issuance of Common Stock upon conversion of preferred stock, shares (145) 16,496 [1]      
Issuance of Common Stock upon exercise of warrants 64 64
Issuance of Common Stock upon exercise of warrants, shares [1]     6,666      
Issuance of Common Stock in exchange for warrants 618 618
Issuance of Common Stock in exchange for warrants, shares [1]     31,111      
Deemed dividend (618) (618)
Balance at Sep. 30, 2025 215,335 (208,875) 6,460
Balance, shares at Sep. 30, 2025 3,155 393,405 [1]      
Balance at Dec. 31, 2025 215,617 (210,787) 4,830
Balance, shares at Dec. 31, 2025 3,155 427,079 [1]      
Share-based compensation 113 113
Net loss (1,921) (1,921)
Balance at Mar. 31, 2026 215,730 (212,708) 3,022
Balance, shares at Mar. 31, 2026 3,155 427,079 [1]      
Balance at Dec. 31, 2025 215,617 (210,787) 4,830
Balance, shares at Dec. 31, 2025 3,155 427,079 [1]      
Net loss           (5,012)
Balance at Sep. 30, 2026 225,848 (222,920) 2,928
Balance, shares at Sep. 30, 2026 2,171 575 1,100,281 [1]      
Balance at Mar. 31, 2026 215,730 (212,708) 3,022
Balance, shares at Mar. 31, 2026 3,155 427,079 [1]      
Share-based compensation 104 104
Net loss (1,326) (1,326)
Balance at Jun. 30, 2026 215,834 (214,034) 1,800
Balance, shares at Jun. 30, 2026 3,155 427,079 [1]      
Share-based compensation 100 100
Net loss (1,765) (1,765)
Issuance of Common Stock upon conversion of preferred stock
Issuance of Common Stock upon conversion of preferred stock, shares (984)   187,428 [1]      
Issuance of Common Stock upon exercise of warrants 2,283 2,283
Issuance of Common Stock upon exercise of warrants, shares [1]     485,774      
Issuance of Series D Preferred stock and warrants, net of stock issuance costs $65 510 510
Issuance of Series D Preferred stock and warrants, net of stock issuance costs, shares   575        
Deemed dividend due to Series C Preferred down-round 2,372 (2,372)
Deemed dividend due to 2025 Warrant down-round 1,208 (1,208)
Deemed dividend due to issuance of inducement warrants 3,541 (3,541)
Balance at Sep. 30, 2026 $ 225,848 $ (222,920) $ 2,928
Balance, shares at Sep. 30, 2026 2,171 575 1,100,281 [1]      
[1] Adjusted to reflect the impact of the 1-for-15 reverse stock split effective September 28, 2026.